Late-onset Alzheimer's disease is characterized by its development at or after the age of 65. The most significant risk factor for late-onset Alzheimer's disease is age, as the risk for Alzheimer's doubles every 5 years once the age of 65 is reached. Further demonstrating the link of age to Alzheimer's is the estimation that 1 in 3 individuals over the age of 85 will develop the disease. However, this is not to say that genetic predisposition does not play a role, as the concordance rate of Alzheimer's disease is higher in identical twins than in non-identical twin siblings. Also, a specific allele of the APOE gene is a candidate for increased risk of late-onset Alzheimer's development.
Another form of Alzheimer's is known as familial early-onset Alzheimer's. This rarer form is Alzheimer's has a stronger genetic link and accounts for less than 10% of all Alzheimer's cases. Disease manifestation occurs before the age of 65, hence the moniker early-onset Alzheimer's. Three genes have been identified to increase the risk of this type of Alzheimer's: presenilin-1, presenilin-2, and amyloid precursor protein. These genes are thought to lead to the formation of plaques in the brain that cause cellular damage and neuronal death. This damage leads to eventual cognitive impairment and memory dysfunction.
Warning signs for Alzheimer's include forgetfulness, repeating oneself repeatedly, becoming lost and disorientated in familiar places, and the loss of the ability to perform once routine tasks. Clinicians will perform a mini-mental exam to assess a patient's progression and also rule out other forms of dementia before Alzheimer's is suggested. There is no cure for Alzheimer's disease but treating it early both pharmacologically and emotionally, by joining a support group, may help improve the patient's quality of life and that of their family. For additional information on Alzheimer's care consult your primary care provider or local pharmacist.
References and Statistical Sources:
Bertram, L., and Tanzi, RE. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Reviews Neuro. 2008: 2008 Oct;9(10):768-78.
Mayo Clinic Staff. Early-onset Alzheimer's: When symptoms begin before 65. http://www.mayoclinic.com/health/alzheimers/AZ00009. Accessed 3/8/2010.
Querfurth,HW; LaFerla, FM. Alzheimer's Disease. New England Journal of Medicine. 2010; 362:329-344.
Williamson J, Goldman J, Marder KS. Genetic aspects of Alzheimer disease. Neurologist. 2009 Mar;15(2):80-6.
Published by S.T. Charette
S.T. Charette has been trained as a research scientist in the fields of genetics and immunology. Specifically, in the areas of cancer and diabetes. He is currently earning a Pharm.D. at ACPHS. View profile
- What is Alzheimer's Disease or Alzheimer's Dementia?It is not possible to cure AD; however, there are ways to slow the progression of the disease through medications; proper care; treating other physical or psychiatric illnesses; and making efforts to make patient's li...
- Alzheimer's Disease, Memory Loss, and Its Social and Psychological ConsequencesAlzheimer's disease is not only brings memory loss, but can cause depression for both the patient and caregiver. The cause of the disease is not known, but we do have evidence that can bring forth preventative measur...
- Causes of Alzheimer's Disease: Part 2This article concentrates on the genetic causes of Alzheimer's disease.
- Tips for Stimulating the Minds of Alzheimer's PatientsInformation on various types of stimuli that you can use to reach Alzheimer's patients.
- A Brief Overview of Different Types of DementiaDementia is a disease in which a person becomes disoriented, loses parts of their memory and has trouble performing the daily activities of life.
- The Three Different Types of Alzheimer's Disease
- The Different Types of Alzheimer's
- Understanding Types of Alzheimer's
- 6 Factors You Should Know About Alzheimer's Disease
- What is Early Onset Alzheimer's Disease?
- Unraveling Alzheimer's Disease
- Lost : On Life's Main Street.....The Slow Onset of Alzheimer's Disease



